Cite Filings / CMPX / 0001193125-22-207846

Feed Companies Filings Check

Sign in

424B5

Prospectus

Compass Therapeutics, Inc. Filed 2022-08-01 Acc 0001193125-22-207846

Documents 1

424B5 Prospectus , d385673d424b5.htm

Around this filing

2025-08-12 424B5 Prospectus
2022-08-02 4 CHIEF EXECUTIVE OFFICER bought 15,000 shares at $2.58 ($38,700)
2022-08-01 424B5 Prospectus
2022-08-01 8-K Material agreement · Agreement ended
2022-08-01 10-Q Quarterly Report
2021-12-15 424B5 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d385673d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…